Neck Reoperation for Recurrent or Persistent Renal Hyperparathyroidism.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
accepted:
30
07
2023
medline:
23
10
2023
pubmed:
16
9
2023
entrez:
15
9
2023
Statut:
ppublish
Résumé
Patients with renal hyperparathyroidism undergoing parathyroidectomy may experience relapse. Reoperation for persistent or recurrent disease, particularly in the neck region, is challenging and has a high complication rate because of difficult exploration. We aimed to evaluate the effectiveness of neck reoperation in renal hyperparathyroidism. Patients with recurrent or persistent renal hyperparathyroidism who underwent neck reoperation between January 2015 and August 2022 were investigated, focusing on operative findings, perioperative biochemical changes, and significance of intraoperative parathyroid hormone (PTH) measurements. During reoperation, 35 parathyroid glands were identified and removed from the 26 enrolled patients, with one, two, and three glands retrieved from 19 (73.2%), five (19.2%), and two (7.6%) patients, respectively. Most removed glands (68.6%) were located in the lower neck, followed by the mediastinum, carotid sheath, and upper neck. Successful resection, defined as a postoperative PTH level of <300 pg/mL, was achieved in 21 patients (80.8%). The remaining four (15.4%) and one (3.9%) patients were classified as having persistent and recurrent disease, respectively. The extent of PTH reduction was correlated with specimen weight, specimen volume, and preoperative alkaline phosphatase (ALP) level. The mean intraoperative PTH ratio (10 min after excision/pre-excision) was 0.23, and all patients with persistent or recurrent disease had a PTH ratio >0.3. Severe hypocalcemia (<7.5 mg/dL) occurred in 19 (73.0%) patients after reoperation. Neck reoperation is an effective therapeutic option in patients with recurrent or persistent renal hyperparathyroidism. A decrease in PTH level by >70% during reoperation (PTH ratio <0.3) predicts successful resection.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with renal hyperparathyroidism undergoing parathyroidectomy may experience relapse. Reoperation for persistent or recurrent disease, particularly in the neck region, is challenging and has a high complication rate because of difficult exploration. We aimed to evaluate the effectiveness of neck reoperation in renal hyperparathyroidism.
METHODS
METHODS
Patients with recurrent or persistent renal hyperparathyroidism who underwent neck reoperation between January 2015 and August 2022 were investigated, focusing on operative findings, perioperative biochemical changes, and significance of intraoperative parathyroid hormone (PTH) measurements.
RESULTS
RESULTS
During reoperation, 35 parathyroid glands were identified and removed from the 26 enrolled patients, with one, two, and three glands retrieved from 19 (73.2%), five (19.2%), and two (7.6%) patients, respectively. Most removed glands (68.6%) were located in the lower neck, followed by the mediastinum, carotid sheath, and upper neck. Successful resection, defined as a postoperative PTH level of <300 pg/mL, was achieved in 21 patients (80.8%). The remaining four (15.4%) and one (3.9%) patients were classified as having persistent and recurrent disease, respectively. The extent of PTH reduction was correlated with specimen weight, specimen volume, and preoperative alkaline phosphatase (ALP) level. The mean intraoperative PTH ratio (10 min after excision/pre-excision) was 0.23, and all patients with persistent or recurrent disease had a PTH ratio >0.3. Severe hypocalcemia (<7.5 mg/dL) occurred in 19 (73.0%) patients after reoperation.
CONCLUSIONS
CONCLUSIONS
Neck reoperation is an effective therapeutic option in patients with recurrent or persistent renal hyperparathyroidism. A decrease in PTH level by >70% during reoperation (PTH ratio <0.3) predicts successful resection.
Identifiants
pubmed: 37714965
doi: 10.1007/s00268-023-07172-5
pii: 10.1007/s00268-023-07172-5
doi:
Substances chimiques
Parathyroid Hormone
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2784-2791Informations de copyright
© 2023. The Author(s) under exclusive licence to Société Internationale de Chirurgie.
Références
Steffen L, Moffa G, Muller PC et al (2019) Secondary hyperparathyroidism: recurrence after total parathyroidectomy with autotransplantation. Swiss Med Wkly 149:w20160
pubmed: 31800966
Fuller DS, Dluzniewski PJ, Cooper K et al (2020) Combinations of mineral and bone disorder markers and risk of death and hospitalizations in the international Dialysis Outcomes and Practice Patterns Study. Clin Kidney J 13:1056–1062
doi: 10.1093/ckj/sfz112
pubmed: 33391749
Dream S, Kuo LE, Kuo JH et al (2022) The American association of endocrine surgeons guidelines for the definitive surgical management of secondary and tertiary renal hyperparathyroidism. Ann Surg 276:e141–e176
doi: 10.1097/SLA.0000000000005522
pubmed: 35848728
Ketteler M, Block GA, Evenepoel P et al (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int 92:26–36
doi: 10.1016/j.kint.2017.04.006
pubmed: 28646995
Komaba H, Taniguchi M, Wada A et al (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88:350–359
doi: 10.1038/ki.2015.72
pubmed: 25786097
Tominaga Y, Uchida K, Haba T et al (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38:S168-171
doi: 10.1053/ajkd.2001.27432
pubmed: 11576947
Matsuoka S, Tominaga Y, Sato T et al (2007) Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 31:299–305
doi: 10.1007/s00268-006-0391-z
pubmed: 17219279
Tominaga Y, Matsuoka S, Uno N et al (2010) Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg 34:1312–1317
doi: 10.1007/s00268-010-0412-9
pubmed: 20130870
Dotzenrath C, Cupisti K, Goretzki E et al (2003) Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 387:348–354
doi: 10.1007/s00423-002-0322-x
pubmed: 12536330
Kievit AJ, Tinnemans JG, Idu MM et al (2010) Outcome of total parathyroidectomy and autotransplantation as treatment of secondary and tertiary hyperparathyroidism in children and adults. World J Surg 34:993–1000
doi: 10.1007/s00268-010-0446-z
pubmed: 20145928
pmcid: 2848726
Cattan P, Halimi B, Aïdan K et al (2000) Reoperation for secondary uremic hyperparathyroidism: are technical difficulties influenced by initial surgical procedure? Surgery 127:562–565
doi: 10.1067/msy.2000.105865
pubmed: 10819065
Zhu L, Cheng F, Zhu X et al (2020) Safety and effectiveness of reoperation for persistent or recurrent drug refractory secondary hyperparathyroidism. Gland Surg 9:401–408
doi: 10.21037/gs-20-391
pubmed: 32420265
pmcid: 7225451
Chou FF, Lee CH, Chen HY et al (2002) Persistent and recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation. Ann Surg 235:99–104
doi: 10.1097/00000658-200201000-00013
pubmed: 11753048
pmcid: 1422401
Agha A, Loss M, Schlitt HJ et al (2012) Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects. Eur Arch Otorhinolaryngol 269:1519–1525
doi: 10.1007/s00405-011-1776-7
pubmed: 21990052
Patow CA, Norton JA, Brennan MF (1986) Vocal cord paralysis and reoperative parathyroidectomy. A prospective study. Ann Surg 203:282–285
doi: 10.1097/00000658-198603000-00011
pubmed: 3954480
pmcid: 1251091
Hindié E, Zanotti-Fregonara P, Just PA et al (2010) Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism. Eur J Nucl Med Mol Imaging 37:623–634
doi: 10.1007/s00259-009-1313-8
pubmed: 19946686
Yeh R, Tay YD, Dercle L et al (2020) A simple formula to estimate parathyroid weight on 4D-CT, predict pathologic weight, and diagnose parathyroid adenoma in patients with primary hyperparathyroidism. AJNR Am J Neuroradiol 41:1690–1697
pubmed: 32816774
pmcid: 7583096
Goldfarb M, Gondek SS, Lim SM et al (2012) Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg 36:1314–1319
doi: 10.1007/s00268-012-1560-x
pubmed: 22399154
Ho LY, Wong PN, Sin HK et al (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18:12
doi: 10.1186/s12882-016-0421-5
pubmed: 28073343
pmcid: 5223390
Haustein SV, Mack E, Starling JR, et al (2005) The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. Surgery 138:1066–1071. Discussion 1071
Triponez F, Dosseh D, Hazzan M et al (2006) Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. Langenbecks Arch Surg 391:561–565
doi: 10.1007/s00423-006-0070-4
pubmed: 16909294
Hibi Y, Tominaga Y, Sato T et al (2002) Reoperation for renal hyperparathyroidism. World J Surg 26:1301–1307
doi: 10.1007/s00268-002-6731-8
pubmed: 12205559
Schneider R, Bartsch DK, Schlosser K (2013) Relevance of bilateral cervical thymectomy in patients with renal hyperparathyroidism: analysis of 161 patients undergoing reoperative parathyroidectomy. World J Surg 37:2155–2161
doi: 10.1007/s00268-013-2091-9
pubmed: 23674256
Seehofer D, Steinmüller T, Rayes N et al (2004) Parathyroid hormone venous sampling before reoperative surgery in renal hyperparathyroidism: comparison with noninvasive localization procedures and review of the literature. Arch Surg 139:1331–1338
doi: 10.1001/archsurg.139.12.1331
pubmed: 15613292
Majors JD, Burke GJ, Mansberger AR Jr et al (1995) Technetium Tc 99m sestamibi scan for localizing abnormal parathyroid glands after previous neck operations: preliminary experience in reoperative cases. South Med J 88:327–330
doi: 10.1097/00007611-199503000-00016
pubmed: 7886531
Stephen AE, Roth SI, Fardo DW et al (2007) Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg 142:381–386
doi: 10.1001/archsurg.142.4.381
pubmed: 17441292
Schlosser K, Sitter H, Rothmund M et al (2004) Assessing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. World J Surg 28:583–588
doi: 10.1007/s00268-004-7321-8
pubmed: 15366749
Wen P, Xu L, Zhao S et al (2021) Risk Factors for Severe Hypocalcemia in Patients with Secondary Hyperparathyroidism after Total Parathyroidectomy. Int J Endocrinol 2021:6613659
doi: 10.1155/2021/6613659
pubmed: 33868402
pmcid: 8035008
Cheng SP, Liu CL, Chen HH et al (2009) Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism. World J Surg 33:72–79
doi: 10.1007/s00268-008-9787-2
pubmed: 18953601